EMTRICITABINE/RILPIVIRINE/TENOFOVIR - ORAL
PHONETIC PRONUNCIATION: (EM-trye-SYE-ta-been/RIL-pi-VIR-een/ten-OF-oh-vir)
COMMON BRAND NAME(S): Complera
GENERIC NAME(S): emtricitabine/rilpivirine HCl/tenofovir disoproxil fumarate
Uses
USES: This product contains 3 different medications: emtricitabine, rilpivirine, and tenofovir. It is used to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Emtricitabine and tenofovir belong to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). Rilpivirine belongs to a class of drugs known as non-nucleoside reverse transcriptase inhibitors (NNRTIs). Emtricitabine/rilpivirine/tenofovir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, do all of the following: (1) continue to take all HIV medications exactly as prescribed by your doctor, (2) always use an effective barrier method (latex or polyurethane condoms/dental dams) during all sexual activity, and (3) do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.
How to use EMTRICITABINE/RILPIVIRINE/TENOFOVIR - ORAL
HOW TO USE: Read the Patient Information Leaflet if available from your pharmacist before you start taking this medication and each time you get a refill. If you have any questions, ask your doctor or pharmacist. Take this medication by mouth with food as directed by your doctor, usually once daily. Medications which reduce or block stomach acid (such as proton pump inhibitors/PPIs, H2 blockers, antacids) may reduce the absorption of rilpivirine, making it work less well. Do not take PPIs (such as omeprazole, lansoprazole) while using this medication. If you take antacids, take the antacids at least 2 hours before or at least 4 hours after this medication. If you take H2 blockers (such as famotidine, ranitidine), take them at least 12 hours before or at least 4 hours after this medication. It is very important to continue taking this medication exactly as prescribed by your doctor. Do not take less of this drug than prescribed or stop taking it even for a short time unless directed to do so by your doctor. Doing so may cause the amount of virus to increase and/or make the infection more difficult to treat (resistant). Do not increase your dose or take this medication more often than prescribed. Your condition will not improve any faster, and your risk of side effects may increase. For the best effect, take this medication at evenly spaced times. To help you remember, take this medication at the same time every day.
Side Effects
Precautions
Interactions
Overdose
Images
Reviews
Faq for EMTRICITABINE/RILPIVIRINE/TENOFOVIR - ORAL
Emtricitabine/Rilpivirine/Tenofovir is a combination medication used to treat HIV infection. It contains three different antiviral drugs: emtricitabine, rilpivirine, and tenofovir.
Emtricitabine/Rilpivirine/Tenofovir works by inhibiting the replication of HIV in the body. The three drugs work together to prevent the virus from multiplying and spreading, thus helping to control the infection.
Common side effects of this medication may include diarrhea, headache, dizziness, nausea, and trouble sleeping. It is important to notify your healthcare provider if any side effects become severe or persistent.
Emtricitabine/Rilpivirine/Tenofovir is usually taken as a once-daily oral tablet with or without food. It is important to follow your healthcare provider's instructions regarding dosage and administration.
It is generally recommended to avoid alcohol while taking this medication as it may increase the risk of liver toxicity and side effects. Please consult with your healthcare provider for specific guidance.
If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.
The use of this medication during pregnancy is generally considered safe and effective in controlling HIV infection. However, it is important to discuss the potential risks and benefits with your healthcare provider.
No, there are several other medications and combination therapies available for the treatment of HIV. The choice of treatment depends on various factors and is determined by a healthcare professional.
No, there is currently no cure for HIV. However, this medication can help control the infection and reduce the viral load in the body, improving health outcomes and reducing the risk of transmission.
Warning
WARNING: If you have hepatitis B infection, your hepatitis symptoms may get worse or become very serious if you stop taking this medication. Talk with your doctor before stopping this medication. Your doctor will monitor liver tests for several months after you stop emtricitabine/rilpivirine/tenofovir. Tell your doctor right away if you have symptoms of worsening liver problems.
Disclaimer
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
No Reviews Yet